Pascal Prigent
Chief Executive Officer bei GENFIT
Vermögen: 110 770 $ am 31.03.2024
Profil
Pascal Prigent is currently the Chief Executive Officer at Genfit SA. Previously, he held the position of Vice President & General Manager at GlaxoSmithkline SRL from 2011 to 2014, and Vice President-Marketing at GlaxoSmithKline LLC from 2014 to 2017.
Mr. Prigent obtained an MBA from INSEAD in 1995 and an undergraduate degree from NEOMA Business School in 1989.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
GENFIT SA
0,06% | 01.04.2024 | 30 708 ( 0,06% ) | 110 770 $ | 31.03.2024 |
Aktive Positionen von Pascal Prigent
Unternehmen | Position | Beginn |
---|---|---|
GENFIT | Chief Executive Officer | 16.09.2019 |
Ehemalige bekannte Positionen von Pascal Prigent
Unternehmen | Position | Ende |
---|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Sales & Marketing | 01.11.2017 |
GlaxoSmithkline SRL
GlaxoSmithkline SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithkline SRL is a Romanian subsidiary company that operates within the pharmaceutical industry. As a part of the larger GSK Plc, GlaxoSmithkline benefits from the resources and expertise of its parent company. It is involved in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription medicines, vaccines, and consumer healthcare products. With a strong focus on innovation and improving global health, GlaxoSmithkline plays a significant role in providing healthcare solutions to people around the world. | Corporate Officer/Principal | 01.03.2014 |
Ausbildung von Pascal Prigent
INSEAD | Masters Business Admin |
NEOMA Business School | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GENFIT | Health Technology |
Private Unternehmen | 2 |
---|---|
GlaxoSmithkline SRL
GlaxoSmithkline SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithkline SRL is a Romanian subsidiary company that operates within the pharmaceutical industry. As a part of the larger GSK Plc, GlaxoSmithkline benefits from the resources and expertise of its parent company. It is involved in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription medicines, vaccines, and consumer healthcare products. With a strong focus on innovation and improving global health, GlaxoSmithkline plays a significant role in providing healthcare solutions to people around the world. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |